Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Trading Down 0.1% – Here’s Why

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) shares traded down 0.1% during mid-day trading on Wednesday . The stock traded as low as $25.18 and last traded at $25.27. 6,189 shares were traded during mid-day trading, a decline of 8% from the average session volume of 6,704 shares. The stock had previously closed at $25.30.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Trading Down 0.1 %

The company’s 50-day simple moving average is $25.30 and its 200 day simple moving average is $25.35.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Wednesday, January 15th were given a dividend of $0.5391 per share. This is a boost from Harrow Health, Inc. 8.625% Senior Notes due 2026’s previous quarterly dividend of $0.54. The ex-dividend date of this dividend was Wednesday, January 15th. This represents a $2.16 dividend on an annualized basis and a yield of 8.53%.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.